Obéric L - Search Results

1

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia.

Gauthier M, Durrieu F, Martin E, Peres M, Vergez F, Filleron T, Obéric L, Bijou F, Quillet Mary A, Ysebaert L. Gauthier M, et al. Among authors: oberic l. BMC Cancer. 2019 Aug 14;19(1):809. doi: 10.1186/s12885-019-5971-z. BMC Cancer. 2019. PMID: 31412798 Free PMC article.

2

Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.

Rossignol J, Michallet AS, Oberic L, Picard M, Garon A, Willekens C, Dulery R, Leleu X, Cazin B, Ysebaert L. Rossignol J, et al. Among authors: oberic l. Leukemia. 2011 Mar;25(3):473-8. doi: 10.1038/leu.2010.278. Epub 2010 Dec 3. Leukemia. 2011. PMID: 21127498

3

Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: the Ambulatory Medical Assistance (AMA) experience.

Compaci G, Ysebaert L, Obéric L, Derumeaux H, Laurent G. Compaci G, et al. Among authors: oberic l. Int J Nurs Stud. 2011 Aug;48(8):926-32. doi: 10.1016/j.ijnurstu.2011.01.008. Epub 2011 Feb 23. Int J Nurs Stud. 2011. PMID: 21349519

4

Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia.

Bouvet E, Borel C, Obéric L, Compaci G, Cazin B, Michallet AS, Laurent G, Ysebaert L. Bouvet E, et al. Among authors: oberic l. Haematologica. 2013 Jan;98(1):65-70. doi: 10.3324/haematol.2012.070755. Epub 2012 Oct 12. Haematologica. 2013. PMID: 23065520 Free PMC article.

5

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis.

Michallet AS, Cazin B, Bouvet E, Oberic L, Schlaifer D, Mosser L, Salles G, Coiffier B, Laurent G, Ysebaert L. Michallet AS, et al. Among authors: oberic l. J Geriatr Oncol. 2013 Apr;4(2):141-7. doi: 10.1016/j.jgo.2013.01.002. Epub 2013 Feb 26. J Geriatr Oncol. 2013. PMID: 24071539

6

Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high-risk relapsed/refractory chronic lymphocytic leukemia patients.

Oberic L, Vaillant W, Hebraud B, Recher C, Suc E, Houyau P, Laurent G, Ysebaert L. Oberic L, et al. Eur J Haematol. 2015 Jan;94(1):37-42. doi: 10.1111/ejh.12391. Epub 2014 Sep 17. Eur J Haematol. 2015. PMID: 24939411

7

Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas.

Perry M, Delarche A, Ribes D, Vergez F, Guilbeau-Frugier C, Laurent C, Huart A, Tavitian S, El Hachem H, Oberic L, Chauveau D, Michallet AS, Ysebaert L, Faguer S. Perry M, et al. Among authors: oberic l. Am J Hematol. 2014 Oct;89(10):969-73. doi: 10.1002/ajh.23798. Epub 2014 Jul 30. Am J Hematol. 2014. PMID: 25043930 Free article. Clinical Trial.

8

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

Alcantara M, Dupuis J, Mareschal S, Julian A, Cottereau AS, Becker S, Dubois S, Oberic L, Huynh A, Meignan M, Laurent G, Tilly H, Haioun C, Ysebaert L. Alcantara M, et al. Among authors: oberic l. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):215-21. doi: 10.1007/s00259-014-2896-2. Epub 2014 Sep 20. Eur J Nucl Med Mol Imaging. 2015. PMID: 25239490

9

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.

Bertoli S, Sterin A, Tavitian S, Oberic L, Ysebaert L, Bouabdallah R, Vergez F, Sarry A, Bérard E, Huguet F, Laurent G, Prébet T, Vey N, Récher C. Bertoli S, et al. Among authors: oberic l. Oncotarget. 2016 Dec 27;7(52):85937-85947. doi: 10.18632/oncotarget.13262. Oncotarget. 2016. PMID: 27852053 Free PMC article.

10

Impaired functional responses in follicular lymphoma CD8⁺TIM-3⁺ T lymphocytes following TCR engagement.

Gravelle P, Do C, Franchet C, Mueller S, Oberic L, Ysebaert L, Larocca LM, Hohaus S, Calmels MN, Frenois FX, Kridel R, Gascoyne RD, Laurent G, Brousset P, Valitutti S, Laurent C. Gravelle P, et al. Among authors: oberic l. Oncoimmunology. 2016 Aug 24;5(10):e1224044. doi: 10.1080/2162402X.2016.1224044. eCollection 2016. Oncoimmunology. 2016. PMID: 27990323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page